TransCode Therapeutics, Inc.
RNAZ
$8.95
-$0.34-3.66%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/17/2025
-
GuruFocus
11/17/2025
-
PR Newswire
11/16/2025
-
Ticker Report
11/15/2025
-
GuruFocus
10/27/2025
-
TipRanks Financial Blog
10/14/2025
-
GuruFocus
10/14/2025
-
GuruFocus
10/14/2025
-
The Fly
10/14/2025
-
PR Newswire
10/9/2025
-
South China Morning Post - Companies
10/8/2025
-
RTT News - Momentum Stocks
10/8/2025
-
Benzinga
10/8/2025
-
The Fly
10/8/2025
-
The Fly
10/8/2025
-
GuruFocus
10/8/2025
-
Stocktwits News Feed
10/8/2025
-
The Fly
9/8/2025
-
Ticker Report
9/2/2025
-
TipRanks Financial Blog
8/18/2025
-
Ticker Report
7/23/2025
-
GuruFocus
7/23/2025
-
TipRanks Financial Blog
7/23/2025
-
The Fly
7/23/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Apr 13 and 17 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857-837-3099
Address
6 Liberty Square
Boston, MA 02109
Boston, MA 02109
Country
Year Founded
Business Description
Sector
TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer. The company’s lead therapeutic...
more